Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-06-17FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca Pharmaceuticals LP. This action modifies the product l…
-
FDA label_change · 2016-06-17FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) to update the labeling language.
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Lifestyle Intervention for Diabetes and Weight Management in Psychosis [NA]
A completed clinical trial evaluating a lifestyle intervention for diabetes management and weight loss in individuals with psychotic disorde…
-
FDA approval · 2016-06-17FDA Approved: LAMOTRIGINE — Original Application (Dr. Reddys Laboratories Inc.)
The FDA approved the original application for a generic Lamotrigine product from Dr. Reddys Laboratories Inc.
-
CLINICAL_TRIALS research · 2016-06-08Clinical Trial Update: Mental Time Travel and Identity in Bipolar Disorder Patients [NA]
This clinical trial entry investigates mental time travel and identity in individuals with bipolar disorder. The study status is currently u…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: Effects of Psycho-education of Patients With Bipolar Disorder [NA]
A completed clinical trial evaluating the effects of psycho-education for patients with Bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: NMDA Antagonists in Bipolar Depression [Phase 4]
A Phase 4 clinical trial evaluating NMDA antagonists for bipolar depression has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI
This clinical trial updates a head-to-head comparison of aripiprazole and risperidone on brain morphology using MRI in people with first-epi…
-
FDA approval · 2016-05-27FDA Approved: LITHOBID — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lithobid (lithium carbonate) submitted by ANI Pharmaceuticals, Inc. The approval updates labelin…
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
This completed trial compared aripiprazole with higher metabolic-risk antipsychotics to evaluate adiposity changes via MRI in individuals wi…
-
CLINICAL_TRIALS withdrawal · 2016-05-24Clinical Trial Update: Neuropsychological Characterization of Patients With Bipolar Disorder and a History of Suicide Attempt
ClinicalTrials.gov entry reports the withdrawal of a study assessing neuropsychological characteristics of patients with bipolar disorder an…
-
FDA label_change · 2016-05-19FDA Approved: DIVALPROEX SODIUM — Supplemental Application (NorthStar Rx LLC)
FDA supplemental application for divalproex sodium filed by NorthStar Rx LLC, likely involving labeling updates or other product changes. Th…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Multimodal Neuroimaging of Treatment Effects in Adolescent Mania [NA]
The trial status indicates completion of a multimodal neuroimaging study evaluating treatment effects in adolescent mania within bipolar dis…
-
CLINICAL_TRIALS research · 2016-05-18Clinical Trial Update: Mindfulness Based Cognitive Therapy for Youth With Anxiety at Risk for Bipolar Disorder [NA]
The clinical trial update notes that Mindfulness Based Cognitive Therapy for youth with anxiety at risk for bipolar disorder has completed. …
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Mindfulness in Mood Dysregulated Youth [NA]
This clinical trial update notes the completed status of a mindfulness-based intervention study for mood-dysregulated youth, focusing on bip…
-
FDA approval · 2016-05-17FDA Approved: QUETIAPINE FUMARATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for a generic version of quetiapine fumarate by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS withdrawal · 2016-05-17Clinical Trial Update: A Trial of Cognitive Training in Euthymic Bipolar Disorder [NA]
The trial 'A Trial of Cognitive Training in Euthymic Bipolar Disorder' sponsored by the University of Calgary has been withdrawn; no results…
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder [Phase 3]
A Phase 3 trial evaluating ramelteon sublingual for acute depressive episodes in adults with bipolar I disorder was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder [Phase 3]
A Phase 3 trial evaluating ramelteon sublingual as adjunctive maintenance therapy for Bipolar I Disorder was terminated, and efficacy and sa…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists [Phase 3]
Phase 3 clinical trial evaluating glucagon-like peptide-1 (GLP-1) agonists for cognitive dysfunction in bipolar disorder and major depressiv…
-
FDA approval · 2016-05-12FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote ER (divalproex sodium) submitted by AbbVie.
-
FDA approval · 2016-05-06FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Lithium Carbonate submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Bipolar Cohort Neunkirchen, Final Statement
The Neunkirchen bipolar disorder cohort clinical trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Riluzole to Treat Depression in Bipolar Disorder [Phase 2]
Phase 2 trial of riluzole for bipolar disorder was terminated; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: The Antidepressant Efficacy of the Anticholinergic Scopolamine [Phase 2]
A Phase 2 trial evaluated the antidepressant efficacy of scopolamine in unipolar and bipolar depression. The study was terminated and result…